Last updated on August 9, 2026
The Interventional Radiology Society of Australasia (IRSA) is pleased to announce the publication of its inaugural Quality Care Guidelines for Renal Tumour Ablation. The evidence-based guidelines provide a framework for delivering high-quality, patient-centred care across Australia and New Zealand, from patient selection through to long-term follow-up.
Key highlights include:
- Cryoablation, microwave ablation and radiofrequency ablation are effective first-line treatments for T1a renal cell carcinoma (≤4 cm), with long-term cancer-specific outcomes comparable to surgery.
- Image-guided renal tumour ablation preserves renal function and is typically associated with a short hospital stay.
- The guidelines provide a consistent benchmark for patient selection, procedural technique and follow-up.
Read the full guideline here:

